Please note different locations each day.

Day 1 – Monday, Nov. 18, 2024

Eric P. Newman Education Center (EPNEC) Auditorium
320 S. Euclid Ave., first floor auditorium

Noon-1 p.m. Light Lunch

1-1:15 p.m. Opening Remarks

  • Craig Buchman, MD, Washington University
  • Linda Richards, PhD, Washington University

1:15-3:15 p.m. Session 1: Genetics / Gene Therapy

  • 1:15-1:55 p.m.
    Karen Avraham, PhD, Tel Aviv University
    Gene Discovery to Gene Therapy: A Precision Medicine Approach
  • 1:55-2:35 p.m.
    Zheng-Yi Chen, DPhil, Harvard Medical School
    Gene Therapy for Genetic Hearing Loss: The Future Is Now
  • 2:35-3:15 p.m.
    Michael McKenna, MD, Akouos
    Gene Therapy for Inner Ear Conditions

3:15-3:45 p.m. Coffee Break

3:45-5:25 p.m. Session 2: CMV / Ototoxicity

  • 3:45-4:25 p.m.
    Albert Park, MD, University of Utah
    Using a Murine Model to Elucidate the Host Immune Pathology of Congenital Cytomegalovirus (CMV)
  • 4:25-4:45 p.m.
    Keiko Hirose, MD, Washington University
    Congenital Cytomegalovirus and Antiviral Immunity in the Developing Mouse Cochlea
  • 4:45-5:05 p.m.
    Jinkyung Kim, PhD, Washington University
    In Vivo Tracking of Ototoxic Drug Transport Into the Cochlea
  • 5:05-5:25 p.m.
    Mark Warchol, PhD, Washington University
    Cytoskeletal Response to Ototoxic Injury in the Vestibular Maculae: Implications for Sensory Regeneration
  • 6-7 p.m. Special Lecture
    Frank Lin, MD, PHD, Johns Hopkins University
    Transforming Hearing Through Evidence, Policy and Awareness

Day 2 – Tuesday, Nov. 19, 2024

Jeffrey T. Fort Neuroscience Research Building Auditorium
4370 Duncan Ave., first floor

8:15-8:45 a.m. Light Breakfast

8:45 a.m.-11:35 a.m. Session 3: Hearing Loss

  • 8:45-9:25 a.m.
    John Oghalai, MD, University of Southern California
    Imaging of the Human Ear Using Optical Coherence Tomography
  • 9:25-9:45 a.m.
    Amit Walia, MD, Washington University
    Electrocochleography-Guided Insights in Cochlear Implants: Mapping Place Coding and Intensity-Driven Tonotopic Changes
  • 9:45-10:05 a.m.
    Lavinia Sheets, PhD, Washington University
    From Riverside to Bedside: Zebrafish Insights Into Cisplatin-Induced Hearing Loss

10:05-10:35 a.m. Coffee Break

  • 10:35-10:55 a.m.
    Mark Rutherford, PhD, Washington University
    Sex Dependent Effects of AMPA Receptor Composition on Synaptopathy and Cochlear Function
  • 10:55-11:35 a.m.
    Tobias Moser, MD, University Medical Center Göttingen
    Otoferlin — Related Auditory Synaptopathy

11:35 a.m.-12:35 p.m. Lunch

12:35-2:55 p.m. Session 4: Cortical Mechanisms

  • 12:35-1:15 p.m.
    Anne Takesian, PhD, Harvard Medical School
    Diverse Cortical Layer 1 Circuits for Auditory Perception and Learning
  • 1:15-1:35 p.m.
    Hysell Oviedo, PhD, Washington University
    Asynchronous Development of the Mouse Auditory Cortex Is Driven by Hemispheric Identity and Sex
  • 1:35-2:15 p.m.
    Maria Geffen, PhD, University of Pennsylvania
    Cortical Circuits for Dynamic Auditory Perception
  • 2:15-2:55 p.m.
    Shihab Shamma, PhD, University of Maryland
    1) Washington University’s Pivotal Contributions to Auditory Neuroscience and Research
    and
    2) The Auditory Cortex as a Sensorimotor Fulcrum for Speech and Music Perception

2:55-3:25 p.m. Coffee Break

3:25-5:45 p.m. Session 5: Hearing Loss / Cognitive Impairment

  • 3:25-4:05 p.m.
    Frank Lin, MD, PhD, Johns Hopkins University
    Hearing Intervention, Cognition, and Brain Health: Results From the Aging and Cognitive Health Evaluation in Elders (ACHIEVE) Randomized Trial
  • 4:05-4:45 p.m.
    Willa Brenowitz, PhD, MPH, Kaiser Permanente Center for Health Research
    What Explains the Associations Between Hearing Loss and Dementia?: Evaluating Alternative Pathways With Observational Data
  • 4:45-5:05 p.m.
    Kate McClannahan, AuD, PhD, Washington University
    Self- and Informant-Reported Hearing Difficulties in Adults With Mild Dementia
  • 5:05-5:45 p.m.
    Justin Golub, MD, Columbia University
    When Should We Start Treating Age-Related Hearing Loss?

5:45-6 p.m. Closing Remarks

  • Craig Buchman, MD, Washington University
  • Linda Richards, PhD, Washington University